Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
Cancer
-
-
AgrochemicalsGlobal Market
BCI Pharma Collaborated with Mithra to Identify Novel Therapy for Endometriosis and Cancer in Women.
by adminby adminSynopsis : BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the right relating to…
-
Synopsis: Consultant uro-oncologist and robotic surgeon Abhay Kumar of Medica Superspecialty Hospital (MSH) said this robot-assisted surgery allowed a surgeon to go…
-
AgrochemicalsSanofi Inc.
Sanofi’s Isatuximab Added to RVd Boosts Response in Multiple Myeloma
by adminby adminSummary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
-
Summary – Lupin Diagnostics, a 100 percent subsidiary of Lupin Limited, has set up a state-of-the-art 45,000 sq. ft National Reference Laboratory…
-
AgrochemicalsNuvation Bio
Nuvation Bio Announces FDA Clearance to begin Clinical Trail of NUV-422 for Breast Cancer Treatment.
by adminby adminSummary – U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422. It is a…
-
Summary : SPARC has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of…
-
AgrochemicalsBayer
Bayer’s Nubeqa Ameliorate Endurance in Prostate Cancer Clinical Trial
by adminby adminSummary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
-
Agrochemicals
EUSA Pharma will be Acquired by Italian Firm Recordati for €750 Million Will Boost Rare Disease Offering
by adminby adminItalian drugmaker Recordati has agreed on a price for six-year-old EUSA Pharma. The Milan-based firm will pay €750m ($845 million) for EUSA’s…
-
Agro Science & ResearchSPARC
SPARC gains on antibody licensing agreement with Biomodifying
by adminby adminSynopsis : SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer Sun Pharma Advanced Research Company (SPARC) gained…